Polar Asset Management Partners’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-243,394
Closed -$5M 1124
2022
Q4
$5M Sell
243,394
-695,343
-74% -$12.3M 0.06% 423
2022
Q3
$17.9M Sell
938,737
-71,565
-7% -$1.61M 0.22% 107
2022
Q2
$23.8M Buy
1,010,302
+273,819
+37% +$7.84M 0.28% 67
2022
Q1
$24.1M Sell
736,483
-212,955
-22% -$6.84M 0.26% 65
2021
Q4
$29.5M Buy
949,438
+185,400
+24% +$6.2M 0.31% 55
2021
Q3
$29.1M Buy
764,038
+33,798
+5% +$1.35M 0.29% 69
2021
Q2
$29.3M Buy
730,240
+89,357
+14% +$3.78M 0.3% 61
2021
Q1
$27.8M Buy
640,883
+66,337
+12% +$2.92M 0.27% 58
2020
Q4
$24.7M Buy
574,546
+190,144
+49% +$6.95M 0.27% 69
2020
Q3
$12M Buy
384,402
+106,952
+39% +$3.32M 0.16% 143
2020
Q2
$8.88M Sell
277,450
-171,695
-38% -$5.7M 0.15% 163
2020
Q1
$12.6M Buy
449,145
+53,780
+14% +$2.08M 0.25% 94
2019
Q4
$18.3M Buy
395,365
+388,497
+5,657% +$18.3M 0.35% 72
2019
Q3
$364K Buy
+6,868
New +$354K 0.01% 351

Other funds holding OFIX

Polar Asset Management Partners's OFIX Position: Q1 2023 in Review

Polar Asset Management Partners sold out of Orthofix Medical (OFIX) in Q1 2023, closing a stake of 243,394 shares — an estimated $5M sold.

Polar Asset Management Partners first reported a position in OFIX in Q3 2019 and held it in 14 quarters. The position peaked at $29.5M in Q4 2021. 162 funds tracked by Wall St. Rank hold OFIX as of Q1 2023.

  • Polar Asset Management Partners reported no remaining Orthofix Medical position as of Q1 2023 after selling out during the quarter.
  • Polar Asset Management Partners sold 243,394 Orthofix Medical shares in Q1 2023, an estimated $5M.
  • Polar Asset Management Partners first reported a position in Orthofix Medical in Q3 2019 and held it in 14 quarters.
  • Polar Asset Management Partners's Orthofix Medical position peaked at $29.5M in Q4 2021.
  • 162 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2023.

Based on Polar Asset Management Partners's 13F filing for Q1 2023, filed 15 May 2023.